-
May 22, 2026 Cannabis and ADHDClick here to access CANNABIS AND ADHD – A CADDRA POLICY STATEMENT (2024) Thank you...
-
January 31, 2024 ADHD Medications and Long-Term Risk of CVDCADDRA Board member Dr. Russell J. Schachar provided this commentary on a recently published JAMA...
-
April 25, 2018 Update on BC College’s Stimulant Prescribing StandardsCADDRA - Canadian ADHD Resource Alliance welcomes the revised draft Standard released by the College...
-
May 5, 2016 BC Physicians: Campaign to Add Physician Voice to PharmaCare ADHD ReviewIf you are a medical professional in BC prescribing ADHD medications, please sign this collective letter...
-
December 18, 2015 Public funding disparity across provinces for ADHD medicationTable shows public plan listings by province for stimulants and non-stimulants for treatment of ADHD....
-
December 18, 2015 ODPRN Report Released in OntarioA new Ontario drug class review on medications used in the management of ADHD in...
-
December 8, 2015 Call to BC Government: Extend Coverage to All Long-Acting Meds!Physicians across British Columbia have begun advocacy effects aimed at convincing the BC Government to...
-
November 10, 2015 New CADDRA ADHD Transition FormCADDRA has developed a new from to support the transfer of patients to new healthcare...
-
November 4, 2015 Request for Intuniv Inclusion in Ontario Drug FormularyLetter from Ontario Physicians regarding Intuniv Pediatricians and other physicians in Ontario are invited to...
-
October 27, 2015 Dispelling the Myths & Misinformation about ADHDParents, teachers and healthcare professionals are invited to a special CADDRA-sponsored presentation on child and...
